Non-drug industry funded research

BMJ

Volumn 336, Issue 7634, 2008, Pages 1-2

  Bruzzi, Paolo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Department of Epidemiology and Prevention

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; CLINICAL PRACTICE; CLINICAL STUDY; DRUG APPROVAL; DRUG COST; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; DRUG SAFETY; DRUG USE; EDITORIAL; ETHICS; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE; MEDICAL RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REGISTRATION; STANDARDIZATION; VALIDITY; CLINICAL TRIAL; ECONOMICS;

DRUG;

CLINICAL TRIALS AS TOPIC; DRUG INDUSTRY; PHARMACEUTICAL PREPARATIONS; RESEARCH SUPPORT AS TOPIC;

EID: 38149009800     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39416.559942.BE     Document Type: Editorial

References (8)

1. Berendt L, Håkansson C, Bach KF, Dalhoff K, Andreasen PB, Petersen LG, et al. Effect of European Clinical Trials Directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency 1993-2006. BMJ 2008;336:33-35.
2. Agenzia Italiana del Farmaco. La sperimentazione clinica dei medicinali in Italia - 6° Rapporto Nazionale. 2007. http://oss-sper-clin. agenziafarmaco.it.
3. Baum M, Buzdar AU, Cuzik J, Forbes J, Houghton JH, Klijn JG, et al; ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002;359:2131-9. Erratum, Lancet 2002;360:1520.
4. Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, et al; Intergroup Exemestane Study. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081-92.
5. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-802.
6. Breast International Group (BIG) 1-98 Collaborative Group; Thürlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005;353:2747-57.
7. Mouridsen H, Gershanovich M, Sun Y, Pérez-Carrión R, Boni C, Monnier A, et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001;19:2596-606. Erratum in J Clin Oncol 2001;19:3302.
8. Piccart-Gebhart M. New stars in the sky of treatment for early breast cancer. N Engl J Med 2004;350:1140-2.